-
Publication Venue For
-
Association of Sedentary Behavior With Cancer Mortality in Middle-aged and Older US Adults.
2020
-
Association of Reduced-Intensity Conditioning Regimens With Overall Survival Among Patients With Non-Hodgkin Lymphoma Undergoing Allogeneic Transplant.
2020
-
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial.
2020
-
De-Escalating Breast Cancer Surgery for Low-Risk Ductal Carcinoma in Situ.
2020
-
Incidence of Opioid-Associated Deaths in Cancer Survivors in the United States, 2006-2016: A Population Study of the Opioid Epidemic.
2020
-
Association Between Breastfeeding and Ovarian Cancer Risk..
e200421.
2020
-
Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer.
2020
-
Changing the Course of Cancer Care With Greater Precision.
2020
-
Life Expectancy of Adult Survivors of Childhood Cancer Over 3 Decades.
2020
-
Association Between New Unconfirmed Bone Lesions and Outcomes in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide: Secondary Analysis of the PREVAIL and AFFIRM Randomized Clinical Trials.
2019
-
Exercise and Patients With Cancer-Is It Time to Get Heavier With the Dose?
2019
-
Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.
2019
-
Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer..
1-9.
2019
-
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study.
2019
-
Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial.
2019
-
The Amount of Evidence Needed to Support ERBB2 as a Biomarker for Resistance to EGFR Inhibitors in Metastatic Colorectal Cancer.
2019
-
Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients With Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.
2019
-
Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial.
2019
-
Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality..
5:975-983.
2019
-
Derivation of Anthracycline and Anthraquinone Equivalence Ratios to Doxorubicin for Late-Onset Cardiotoxicity..
5:864-871.
2019
-
Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial..
5:664-670.
2019
-
Assessing the Prognostic Value of the Automated Bone Scan Index for Prostate Cancer-Reply..
5:270-271.
2019
-
Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1-Low/Negative Recurrent or Metastatic HNSCC: The Phase 2 CONDOR Randomized Clinical Trial..
5:195-203.
2019
-
Engaging Patients in Value-Based Cancer Care: A Missed Opportunity..
4:1479-1480.
2018
-
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study..
4:1553-1568.
2018
-
Information Transparency in the Drug Approval Process..
4:1621-1622.
2018
-
Association of Exercise With Mortality in Adult Survivors of Childhood Cancer..
4:1352-1358.
2018
-
Broadening the View of Germline Mutations in Kidney Cancer..
4:1235-1236.
2018
-
Phase 3 Assessment of the Automated Bone Scan Index as a Prognostic Imaging Biomarker of Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial..
4:944-951.
2018
-
Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial..
4:783-790.
2018
-
Study Limitations in HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia-Reply..
4:891.
2018
-
Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features..
4:e175230.
2018
-
"Job Lock" Among Long-term Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study..
4:707-711.
2018
-
Radiographic Progression-Free Survival as a Clinically Meaningful End Point in Metastatic Castration-Resistant Prostate Cancer: The PREVAIL Randomized Clinical Trial..
4:694-701.
2018
-
Seizure Rates in Enzalutamide-Treated Men With Metastatic Castration-Resistant Prostate Cancer and Risk of Seizure: The UPWARD Study..
4:702-706.
2018
-
Association of Tumor HER3 Messenger RNA Expression With Panitumumab Efficacy in Advanced Colorectal Cancer..
4:564-568.
2018
-
Technological Advances, Biologic Rationales, and the Associated Success of Chemotherapy With Hyperthermia in Improved Outcomes in Patients With Sarcoma..
4:493-494.
2018
-
Minimal Residual Disease in Chronic Lymphocytic Leukemia in the Era of Novel Agents: A Review..
4:394-400.
2018
-
Estimating Cost-effectiveness of a Multimodal Ovarian Cancer Screening Program in the United States: Secondary Analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)..
4:190-195.
2018
-
Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer: A Randomized Clinical Trial..
4:196-202.
2018
-
HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia: Results From the Microtransplantation Interest Group..
4:54-62.
2018
-
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015..
3:1683-1691.
2017
-
Out-of-Pocket Costs, Financial Distress, and Underinsurance in Cancer Care..
3:1582-1584.
2017
-
Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study..
3:e172411.
2017
-
Comparison of Patient Report and Medical Records of Comorbidities: Results From a Population-Based Cohort of Patients With Prostate Cancer..
3:1035-1042.
2017
-
Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033..
3:944-952.
2017
-
Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)..
3:827-831.
2017
-
Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study..
3:636-651.
2017
-
Appropriate Use of Antiemetics to Prevent Chemotherapy-Induced Nausea and Vomiting..
3:307-309.
2017
-
Association of a Bundled-Payment Program With Cost and Outcomes in Full-Cycle Breast Cancer Care..
3:327-334.
2017
-
Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1..
1:1319-1323.
2015
-
Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009..
1:1098-1109.
2015
-
Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)..
1:1051-1059.
2015
-
Chemotherapy Use, Performance Status, and Quality of Life at the End of Life..
1:778-784.
2015
-
The Global Burden of Cancer 2013..
1:505-527.
2015
-
Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009..
1:158-166.
2015
-
Midlife Cardiorespiratory Fitness, Incident Cancer, and Survival After Cancer in Men: The Cooper Center Longitudinal Study..
1:231-237.
2015